FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386836929> ?p ?o ?g. }

• W4386836929 abstract "Patients with septic shock caused by Staphylococcus aureus have mortality rates exceeding 50%, despite appropriate antibiotic therapy. Our objectives were to establish a rabbit model of S. aureus septic shock and to determine whether a novel immunotherapy can prevent or halt its natural disease progression.Anesthetized rabbits were ventilated with lung-protective low-tidal volume, instrumented for advanced hemodynamic monitoring, and characterized for longitudinal changes in acute myocardial dysfunction by echocardiography and sepsis-associated biomarkers after S. aureus intravenous challenge. To demonstrate the potential utility of this hyperdynamic septic shock model for preclinical drug development, rabbits were randomized for prophylaxis with anti-Hla/Luk/ClfA monoclonal antibody combination that neutralizes alpha-hemolysin (Hla), the bicomponent pore-forming leukocidins (Luk) including Panton-Valentine leukocidin, leukocidin ED, and gamma-hemolysin, and clumping factor A (ClfA), or an irrelevant isotype-matched control IgG (c-IgG), and then challenged with S. aureus.Rabbits challenged with S. aureus, but not those with saline, developed a hyperdynamic state of septic shock characterized by elevated cardiac output (CO), increased stroke volume (SV) and reduced systemic vascular resistance (SVR), which was followed by a lethal hypodynamic state characterized by rapid decline in mean arterial pressure (MAP), increased central venous pressure, reduced CO, reduced SV, elevated SVR, and reduced left-ventricular ejection fraction, thereby reproducing the hallmark clinical features of human staphylococcal septic shock. In this model, rabbits pretreated with anti-Hla/Luk/ClfA mAb combination had 69% reduction in mortality when compared to those pretreated with c-IgG (P<0.001). USA300-induced acute circulatory failure-defined as >70% decreased in MAP from pre-infection baseline-occurred in only 20% (2/10) of rabbits pretreated with anti-Hla/Luk/ClfA mAb combination compared to 100% (9/9) of those pretreated with c-IgG. Prophylaxis with anti-Hla/Luk/ClfA mAb combination halted progression to lethal hypodynamic shock, as evidenced by significant protection against the development of hyperlactatemia, hypocapnia, hyperkalemia, leukopenia, neutropenia, monocytopenia, lymphopenia, as well as biomarkers associated with acute myocardial injury.These results demonstrate the potential utility of a mechanically ventilated rabbit model that reproduced hallmark clinical features of hyperdynamic septic shock and the translational potential of immunotherapy targeting S. aureus virulence factors for the prevention of staphylococcal septic shock." @default.
• W4386836929 created "2023-09-19" @default.
• W4386836929 creator A5028335052 @default.
• W4386836929 creator A5042507670 @default.
• W4386836929 creator A5049655890 @default.
• W4386836929 creator A5050859911 @default.
• W4386836929 creator A5086304994 @default.
• W4386836929 creator A5090448003 @default.
• W4386836929 date "2023-09-15" @default.
• W4386836929 modified "2023-10-05" @default.
• W4386836929 title "Monoclonal antibodies neutralizing alpha-hemolysin, bicomponent leukocidins, and clumping factor A protected against Staphylococcus aureus-induced acute circulatory failure in a mechanically ventilated rabbit model of hyperdynamic septic shock" @default.
• W4386836929 cites W1523347396 @default.
• W4386836929 cites W1716237860 @default.
• W4386836929 cites W1803784511 @default.
• W4386836929 cites W19461878 @default.
• W4386836929 cites W1973675012 @default.
• W4386836929 cites W1975321661 @default.
• W4386836929 cites W1988289466 @default.
• W4386836929 cites W1991237704 @default.
• W4386836929 cites W1994818796 @default.
• W4386836929 cites W2010194325 @default.
• W4386836929 cites W2011531123 @default.
• W4386836929 cites W2018238850 @default.
• W4386836929 cites W2020410970 @default.
• W4386836929 cites W2027988203 @default.
• W4386836929 cites W2037816205 @default.
• W4386836929 cites W2041644556 @default.
• W4386836929 cites W2043513395 @default.
• W4386836929 cites W2048787993 @default.
• W4386836929 cites W2065921144 @default.
• W4386836929 cites W2069230424 @default.
• W4386836929 cites W2081630781 @default.
• W4386836929 cites W2082439271 @default.
• W4386836929 cites W2084046310 @default.
• W4386836929 cites W2086165685 @default.
• W4386836929 cites W2102820915 @default.
• W4386836929 cites W2141842754 @default.
• W4386836929 cites W2152154097 @default.
• W4386836929 cites W2156502117 @default.
• W4386836929 cites W2157101465 @default.
• W4386836929 cites W2158623850 @default.
• W4386836929 cites W2161881689 @default.
• W4386836929 cites W2162472433 @default.
• W4386836929 cites W2162516878 @default.
• W4386836929 cites W2163053334 @default.
• W4386836929 cites W2164990391 @default.
• W4386836929 cites W2168482920 @default.
• W4386836929 cites W2197105807 @default.
• W4386836929 cites W2296386957 @default.
• W4386836929 cites W2522238408 @default.
• W4386836929 cites W2522760129 @default.
• W4386836929 cites W2565856510 @default.
• W4386836929 cites W2580578310 @default.
• W4386836929 cites W2607187374 @default.
• W4386836929 cites W2620241325 @default.
• W4386836929 cites W2622344311 @default.
• W4386836929 cites W2809136012 @default.
• W4386836929 cites W2919520691 @default.
• W4386836929 cites W2946307971 @default.
• W4386836929 cites W2995055934 @default.
• W4386836929 cites W2995881394 @default.
• W4386836929 cites W2997568896 @default.
• W4386836929 cites W3093543675 @default.
• W4386836929 cites W3153513658 @default.
• W4386836929 cites W3158285667 @default.
• W4386836929 cites W3160357709 @default.
• W4386836929 cites W3202964273 @default.
• W4386836929 cites W4281868931 @default.
• W4386836929 doi "https://doi.org/10.3389/fimmu.2023.1260627" @default.
• W4386836929 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37781371" @default.
• W4386836929 hasPublicationYear "2023" @default.
• W4386836929 type Work @default.
• W4386836929 citedByCount "0" @default.
• W4386836929 crossrefType "journal-article" @default.
• W4386836929 hasAuthorship W4386836929A5028335052 @default.
• W4386836929 hasAuthorship W4386836929A5042507670 @default.
• W4386836929 hasAuthorship W4386836929A5049655890 @default.
• W4386836929 hasAuthorship W4386836929A5050859911 @default.
• W4386836929 hasAuthorship W4386836929A5086304994 @default.
• W4386836929 hasAuthorship W4386836929A5090448003 @default.
• W4386836929 hasBestOaLocation W43868369291 @default.
• W4386836929 hasConcept C126322002 @default.
• W4386836929 hasConcept C203014093 @default.
• W4386836929 hasConcept C2777052132 @default.
• W4386836929 hasConcept C2777628635 @default.
• W4386836929 hasConcept C2777805791 @default.
• W4386836929 hasConcept C2778384902 @default.
• W4386836929 hasConcept C2779489039 @default.
• W4386836929 hasConcept C2781300812 @default.
• W4386836929 hasConcept C523546767 @default.
• W4386836929 hasConcept C54355233 @default.
• W4386836929 hasConcept C71924100 @default.
• W4386836929 hasConcept C86803240 @default.
• W4386836929 hasConceptScore W4386836929C126322002 @default.
• W4386836929 hasConceptScore W4386836929C203014093 @default.
• W4386836929 hasConceptScore W4386836929C2777052132 @default.
• W4386836929 hasConceptScore W4386836929C2777628635 @default.
• W4386836929 hasConceptScore W4386836929C2777805791 @default.
• W4386836929 hasConceptScore W4386836929C2778384902 @default.
• W4386836929 hasConceptScore W4386836929C2779489039 @default.

• next